Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on March 9, 2026

Author Ken Harrow Introduces The Fall of Two Houses: Epic Dark Fantasy of Power and Betrayal
Stalled Luxury Boston Penthouse Sells in 2 Months after Innovative Video Marketing Strategy
Choroideremia Research Foundation Announces Four New Global Grants to Accelerate Vision Science
Web Industries expands thermoset slitting capacity in France to support European aerospace growth
Boston Pads Launches 'Property Vault,' a Powerful Off-Market Listing Database Built for Real Estate Transactions
Landscaping Industry Expands Workforce to Meet Growing Hardscaping Needs
HerAnova™ Publishes Clinical Validation Study of HerResolve™ in the  Journal of Minimally Invasive Gynecology
PrepScholar Launches AI Learning Assistant for SAT Prep
Leverage Launches AI Workforce Productivity Platform to Help Employees Find Information and Work Faster
Rapport Therapeutics与Tenacia Biotechnology宣布达成大中华区RAP-219开发与商业化战略合作
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Is green energy raising your electric bill? Or state policies? It’s complicated.
ETF.com Announces Winners of the 2026 ETF Awards, Celebrating Innovation and Investor Value in a Record-Breaking Year
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼
Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology
Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions